natgillin/translations-raw huggingface dataset:
dextromethorphan – hostemedicin atomoxetin – bruges til at behandle attention deficit hyperactivity disorder (ADHD) pravastatin – bruges til at sænke kolesteroltallet og forebygge hjertesygdom
dextromethorphan – cough medicine atomoxetine – used to treat attention deficit hyperactivity disorder (ADHD) pravastatin – used to lower cholesterol and prevent heart disease
Dextrorphan (aktiv metabolit): AUCinf: ↑ 4%
Dextrorphan (active metabolite): AUCinf: ↑ 4
Deze resultaten wijzen erop dat clopidogrel kan worden toegediend in combinatie met pantoprazol.
These results indicate that clopidogrel can be administered with pantoprazole.
Deze stoffen kunt u vinden in rubriek 6;
Do not take Zyllt:
Deze veranderingen in de lever waren het gevolg van een effect op de leverenzymen van de stofwisseling.
During non clinical studies in rat and baboon, the most frequently observed effects were liver changes.
DFS var det primære effektendepunkt og total overlevelse (OS) var det sekundære effektendepunkt.
Disease-free survival (DFS) was the primary efficacy endpoint and Overall survival (OS) was the secondary efficacy endpoint.
DFS var det primære effektendepunkt, og total overlevelse (OS) var det sekundære effektendepunkt.
Disease-free survival (DFS) was the primary efficacy endpoint and Overall survival (OS) was the secondary efficacy endpoint.
DFS- data var ikke statistisk signifikante, men blev alligevel forbundet med en positiv tendens til fordel for TAC.
DFS data were not statistically significant but were still associated with a positive trend in favour of TAC.
Diabetes
Diabetes.
Diabetes (de typiske symptomer er øget tørst, hyppig vandladning)
Diabetes (typical symptoms are excessive thirst, frequent urination)
diabetes eller forværring af diabetes, forhøjet insulin (et hormon, som styrer blodsukkerniveauet) i blodet
diabetes or worsening of diabetes, increased insulin (a hormone that controls blood sugar levels) in your blood
diabetes eller forværring af diabetes, forhøjet insulin (et hormon, som styrer blodsukkerniveauet) i blodet, øget appetit, appetitløshed og deraf følgende underernæring og lav kropsvægt, nedsat appetit, højt indhold i blodet af triglycerider (et fedtstof), forhøjet kolesterol i blodet.
diabetes or worsening of diabetes, increased insulin (a hormone that controls blood sugar levels) in your blood, increased appetite, loss of appetite resulting in malnutrition and low body weight, decreased appetite, high blood triglycerides (a fat), increased cholesterol in your blood
Diabetes eller problemer med blodsukkerniveauet (påvist i blodprøver)
Diabetes or problems with blood sugar levels (shown in blood tests)
Diabetes er en sygdom, hvor bugspytkirtlen ikke producerer tilstrækkelig insulin til at kontrollere blodglucoseniveauet (sukker), og/eller hvor kroppen ikke kan anvende insulin effektivt.
Diabetes is a disease in which the pancreas does not make enough insulin to control the level of blood glucose (sugar) in the blood and/or when the body is unable to use insulin effectively.
diabetes lejlighedsvist
diabetes occasionally
diabetes leversygdom.
diabetes liver disease.
diabetes mellitus (sukkersyge),
diabetes mellitus,
Diabetes mellitus (sukkersyge, Airexar Spiromax kan forhøje blodsukkeret)
Diabetes mellitus (Aerivio Spiromax may increase your blood sugar)
Diabetes mellitus er en sygdom, som skyldes, at kroppen ikke danner tilstrækkeligt insulin til at kontrollere blodsukkeret
Diabetes mellitus is a disease where your body does not produce enough insulin to control the level of blood sugar.
Diabetes mellitus Hyperglykæmi
Hyperglycaemia
Diabetes mellitus med eller uden vaskulære komplikationer
Diabetes mellitus with or without vascular involvement
diabetes mellitus med vaskulære symptomer
diabetes mellitus with vascular symptoms
Diabetes mellitus og hyperglykæmi Almindelig
Diabetes mellitus and hyperglycaemia Common
Diabetes mellitus og hyperglykæmi Ikke almindelig
Diabetes mellitus and hyperglycaemia Uncommon
Diabetes mellitus og hyperglykæmi2
Diabetes mellitus and hyperglycaemia2
diabetes mellitus symptomatisk hjertesvigt (NYHA-klasse ≥ II)
diabetes mellitus symptomatic heart failure (NYHA Class ≥ II)
diabetes mellitus symptomatisk hjertesvigt (NYHA_klasse ≥ II)
diabetes mellitus symptomatic heart failure (NYHA Class ≥ II)
diabetes mellitus, hyperglykæmi, hyperkaliæmi
diabetes mellitus, hyperglycaemic conditions, hyperkalaemia
diabetes mellitus, hyperinsulinæmi, øget appetit, anoreksi,
diabetes mellitus, hyperinsulinaemia, increased appetite,
diabetes mellitus, hypertriglyceridæmi, hyperkolesterolæmi, hyperlipidæmi
diabetes mellitus, hypertriglyceridaemia, hypercholesterolaemia, hyperlipidaemia
Diabetes mellitus, hypertriglyceridæmi٭
Diabetes mellitus, hypertriglyceridemia
Diabetes mellitus, nedsat nyrefunktion, alder (> 70 år)
Diabetes mellitus, renal impairment, age (> 70 years)
Diabetes mellitus, nedsat nyrefunktion, alder (> 70 år)
Diabetes mellitus, renal impairment, age (>70 years)
Diabetes mellitus, nedsat nyrefunktion, alder (> 70 år).
Diabetes mellitus, renal impairment, age (>70 years)
diabetes mellitus, nedsat nyrefunktion, alder (> 70 år).
Diabetes mellitus, renal impairment, age (>70 years).
Diabetes mellitus: Frekvensen afhænger af tilstedeværelse eller fravær af risikofaktorer (fasteglucose ≥ 5,6 mmol/l, BMI > 30 kg/m2, forhøjede triglycerider, hypertension i anamnesen).
Diabetes Mellitus: Frequency will depend on the presence or absence of risk factors (fasting blood glucose ≥ 5.6 mmol/L, BMI>30kg/m2, raised triglycerides, history of hypertension).
Diabetes patienter
Diabetic patients
Diabetes, da der er rapporteret om forhøjet blodsukker hos patienter i behandling med Kaletra.
Diabetes as increased blood sugars has been reported in patients receiving Kaletra.
Diabetes, da der er rapporteret om forhøjet blodsukker hos patienter i behandling med lopinavir/ritonavir.
Diabetes as increased blood sugars has been reported in patients receiving lopinavir/ritonavir.
diabetes, da timolol kan skjule tegn og symptomer på for lavt blodsukker
diabetes as timolol may mask signs and symptoms of low blood sugar
diabetes, fald i kalium i blodet, fejlernæring, øgede triglycerider i blodet
diabetes, decrease in blood potassium, malnutrition, increased blood triglycerides
Diabetes, Hypokaliæmi, Appetit- forstyrrelser, Underernæring, Hyper- triglyceridæmi
Diabetes, Hypokalaemia, Appetite disorder, Malnutrition, Hypertriglyceridaemia,
Diabetes, Hypokaliæmi, Appetitforstyrrel ser, Underernæring, Hypertriglycerid æmi
Diabetes, Hypokalaemia, Appetite disorder, Malnutrition, Hypertriglyceridae mia
Diabetes, Hypokaliæmi, Appetitforstyrrelser, Underernæring, Hypertriglyceridæmi
Diabetes, Hypokalaemia, Appetite disorder, Malnutrition, Hypertriglyceridaemia,
Diabetes.
Diabetes
Diabetespatienter anbefales derfor altid at bære sukkerholdige produkter på sig
It is therefore recommended that the diabetic patient always carries sugar-containing products.
Diabetespatienter anbefales derfor altid at være i besiddelse af sukkerholdige fødevarer.
It is therefore recommended that the diabetic patient always carries sugar–containing products.
Diabetespatienter anbefales derfor altid at være i besiddelse af sukkerholdige produkter..
It is therefore recommended that the diabetic patient always carries sugar-containing products.
Diabetespatienter, som behandles med insulin eller andiabetika
Diabetic patients treated with insulin or antidiabetics
Diabetespatienterne anbefales derfor altid at være i besiddelse af sukkerholdige produkter.
It is therefore recommended that the diabetic patient always carries sugar-containing products.
Diabetikere, der ammer, kan have behov for regulering af insulindosis og/eller diæt.
Patients with diabetes who are breast-feeding may require adjustments in insulin dose, diet or both.
Diabetikere, der ammer, kan have behov for regulering af insulindosis og/eller diæt.
Patients with diabetes who are breast-feeding may require adjustments in insulin dose, diet, or both.
Diabetisk hyperosmolær koma Diabetisk ketoacidose Hyperglykæmi
Diabetic hyperosmolar coma Diabetic ketoacidosis
Diabetisk hyperosmolær koma Diabetisk ketoacidose Hyperglykæmi
Diabetic hyperosmolar coma Diabetic ketoacidosis Hyperglycaemia
Diabetisk ketoaci- dosea, b
Diabetic ketoacidosisa, b
diabetisk ketoacidose
diabetic ketoacidosis,
diabetisk ketoacidose (en medicinsk nødsituation, hvor et forhøjet niveau af ketonstoffer i blodet opstår som et resultat af, at diabetes er ude af kontrol),
diabetic ketoacidosis (medical emergency due to build-up of ketone bodies in the blood as a result of out-of-control diabetes),
Diabetisk ketoacidose eller diabetisk præ-koma
Diabetic ketoacidosis or diabetic pre-coma
diabetisk ketoacidose eller diabetisk præ-koma.
diabetic ketoacidosis or diabetic pre-coma.
diabetisk ketoacidose eller diabetisk prækoma
diabetic ketoacidosis or diabetic pre-coma
diabetisk ketoacidose eller diabetisk prækoma (farlige komplikationer til sukkersyge)
diabetic ketoacidosis or diabetic pre-coma (dangerous complications of diabetes);
Diabetisk ketoacidose eller diabetisk prækoma.
Diabetic ketoacidosis, diabetic pre-coma.
Diabetisk ketoacidose med eller uden koma
Diabetic ketoacidosis, with or without coma
Diabetisk ketoacidose**
Diabetic ketoacidosis
diabetisk ketoacidose, diabetes mellitus
diabetic ketoacidosis, diabetes mellitus
diabetisk ketoacidose, diabetesfod, alkalose, nedsat appetit, D-vitaminmangel
diabetic ketoacidosis, diabetic foot, alkalosis, decreased appetite, vitamin D deficiency
Diabetisk ketoacidose, diabetisk prækoma
Diabetic ketoacidosis, diabetic pre-coma
Diabetisk ketoacidose, diabetisk prækoma
Diabetic ketoacidosis, diabetic pre-coma.
Diabetisk ketoacidose, diabetisk prækoma
Diabetic ketoacidosis, diabetic pre-coma;
diabetisk ketoacidose, hypoglykæmi, polydipsi
diabetic ketoacidosis, hypoglycaemia,
Diabetisk ketoacidose, praecoma diabeticum
Diabetic ketoacidosis, diabetic pre-coma;
diabetisk ketoacidose.
diabetic ketoacidosis
Diabetisk ketoacidoseC
Diabetic ketoacidosisC
diabetisk ketoacidosee,
diabetes mellitusc,
Diabetisk ketoacidosei
Diabetic Ketoacidosisi
Diabetisk ketoacidosek
Diabetic ketoacidosi sk
Diabetisk ketoacidosek
Diabetic ketoacidosisk
Diabetisk koma
Diabetic coma
Diabetisk maculaødem
Diabetic Macular Oedema
diabetisk maculaødem maculaødem efter enten retinal grenveneokklusion (BRVO) eller retinal centralveneokklusion (CRVO).
diabetic macular oedema macular oedema following either Branch Retinal Vein Occlusion (BRVO) or Central Retinal Vein Occlusion (CRVO)
diabetisk retinopati
diabetic retinopathy,
Diabetisk retinopati (en øjensygdom med relation til sukkersyge, som kan medføre synstab).:Hvis du lider af diabetisk retinopati kan dette forværres, hvis dine blodsukkerniveauer forbedres meget hurtigt.
Diabetic retinopathy (an eye disease related to diabetes which can lead to loss of vision): If you have diabetic retinopathy and your blood sugar level improves very fast, the retinopathy may get worse.
Diabetisk retinopati (en øjensygdom med relation til sukkersyge, som kan medføre tab af synet): Hvis du har en diabetisk retinopati, kan den blive værre, hvis dit blodsukkerniveau forbedres meget hurtigt.
Diabetic retinopathy (an eye disease related to diabetes which can lead to loss of vision): If you have diabetic retinopathy and your blood sugar level improves very fast, the retinopathy may get worse.
Diabetisk retinopati(en øjensygdom med relation til sukkersyge, som kan medføre tab af synet): Hvis du har en diabetisk retinopati, kan den blive værre, hvis dit blodsukkerniveau forbedres meget hurtigt.
Diabetic retinopathy (an eye disease related to diabetes which can lead to loss of vision): If you have diabetic retinopathy and your blood sugar level improves very fast, the retinopathy may get worse.
Diabetiske patienter
Diabetic patients
Diacetylerede monoglycerider
Diacetylated monoglycerides
Diacomit 250 mg hårde kapsler
Diacomit 250 mg hard capsules
Diacomit 250 mg hårde kapsler Diacomit 500 mg hårde kapsler Stiripentol
Diacomit 250 mg hard capsule Diacomit 500 mg hard capsule Stiripentol
Diacomit 250 mg hårde kapsler er lyserøde.
Diacomit 250 mg hard capsule is pink.
Diacomit 250 mg hårde kapsler Stiripentol
Diacomit 250 mg hard capsules Stiripentol
Diacomit 250 mg pulver til mikstur, suspension, i breve Diacomit 500 mg pulver til mikstur, suspension, i breve Stiripentol
Diacomit 250 mg powder for oral suspension in sachet Diacomit 500 mg powder for oral suspension in sachet Stiripentol
Diacomit 250 mg pulver til mikstur, suspension, i breve.
Diacomit 250 mg powder for oral suspension in sachet
Diacomit 250 mg pulver til oral suspension
Diacomit 250 mg powder for oral suspension
Diacomit 250 mg pulver til oral suspension i brev Stiripentol
Diacomit 250 mg powder for oral suspension in sachet Stiripentol
Diacomit 500 mg hårde kapsler
Diacomit 500 mg hard capsules
Diacomit 500 mg hårde kapsler er hvide.
Diacomit 500 mg hard capsules are white.
Diacomit 500 mg hårde kapsler Stiripentol
Diacomit 500 mg hard capsules Stiripentol
Diacomit 500 mg indeholder:
What Diacomit 500 mg contains
Diacomit 500 mg pulver til mikstur, suspension, i breve.
Diacomit 500 mg powder for oral suspension in sachet
Diacomit 500 mg pulver til oral suspension
Diacomit 500 mg powder for oral suspension
Diacomit 500 mg pulver til oral suspension i brev Stiripentol
Diacomit 500 mg powder for oral suspension in sachet Stiripentol
Diacomit anvendes til børn med en meget sjælden type epilepsi kaldet »svær myoklon epilepsi i barndommen« (SMEI), også kendt som Dravets syndrom.
Diacomit is used in children with a very rare type of epilepsy called ‘severe myoclonic epilepsy in infancy’ (SMEI), also known as Dravet’s syndrome.
Diacomit blev oprindeligt godkendt under »særlige omstændigheder«, eftersom der afventedes yderligere dokumentation om lægemidlet, navnlig vedrørende dets kort- og langsigtede virkning og sikkerhed.
Diacomit was originally given ‘conditional approval’ because there was more evidence to come about the medicine, in particular regarding its short-term and long-term effectiveness and safety.
Diacomit er indiceret til anvendelse sammen med clobazam og valproat som adjuverende behandling af refraktær generaliserede tonisk-kloniske kramper hos patienter med Dravet syndrome (Severe Myoclonic Epilepsy in Infancy; SMEI), hvis kramperne ikke kan kontrolleres tilstrækkeligt med clobazam og valproat.
Diacomit is indicated for use in conjunction with clobazam and valproate as adjunctive therapy of refractory generalized tonic-clonic seizures in patients with severe myoclonic epilepsy in infancy (SMEI, Dravet’s syndrome) whose seizures are not adequately controlled with clobazam and valproate.
Diacomit er indiceret til anvendelse sammen med clobazam og valproat som adjuverende behandling af refraktære, generaliserede tonisk-kloniske kramper hos patienter med Dravet syndrome (Severe Myoclonic Epilepsy in Infancy; SMEI), hvis kramperne ikke kan kontrolleres tilstrækkeligt med clobazam og valproat.
Diacomit is indicated for use in conjunction with clobazam and valproate as adjunctive therapy of refractory generalized tonic-clonic seizures in patients with severe myoclonic epilepsy in infancy (SMEI, Dravet’s syndrome) whose seizures are not adequately controlled with clobazam and valproate.
Diacomit må IKKE tages sammen med mælk eller andre mejeriprodukter (youghurt, smøreoste osv.), frugtjuice, kulsyreholdige drikkevarer eller mad og drikkevarer, der indeholder caffein eller theophyllin (for eksempel cola, chokolade, kaffe, te og energidrikke).
Do NOT take Diacomit with milk or dairy products (yoghurt, soft cream cheeses, etc), fruit juice, fizzy drinks or food and drinks that contain caffeine or theophylline (for example cola, chocolate, coffee, tea and energy drinks).
Diacomit pulver til oral suspension i breve indeholder aspartam, som er en kilde til phenylalanin.
Diacomit powder for oral suspension in sachet contains aspartame, a source of phenylalanine.
Diagnosen blev bekræftet ved objektive undersøgelser (lungescanning, lungeangiografi eller spiral CT-scanning).
The diagnosis was confirmed by objective testing (lung scan, pulmonary angiography or spiral CT scan).
Diagnosen PML skal overvejes hos patienter, der får Arzerra, hvor der opstår eller sker ændringer i eksisterende neurologiske fund og symptomer.
A diagnosis of PML should be considered in any Arzerra patient who reports the new onset of or changes in pre-existing neurologic signs and symptoms.
Diagnosen PRES / RPLS skal bekræftes ved hjernescanning.
A diagnosis of PRES/RPLS requires confirmation by brain imaging.
Diagnosen PRES/RPLS skal bekræftes ved hjernescanning.
A diagnosis of PRES/RPLS requires confirmation by brain imaging.
Diagnosen skal bekræftes ved egnede gentest.
The diagnosis must be confirmed by appropriate genetic testing.
Diagnosen TMA skal overvejes ved forekomst af hæmolytisk anæmi, trombocytopeni, træthed, fluktuerende neurologiske manifestationer, nedsat nyrefunktion og feber.
The diagnosis of TMA should be considered in the occurrence of haemolytic anaemia, thrombocytopaenia, fatigue, fluctuating neurologic manifestation, renal impairment and fever.
Diagnosticering af ikke relaterede sygdomstilstande
Diagnosis of unrelated medical conditions
Diagnosticering af laktatacidose
Diagnosis of lactic acidosis
Diagnosticering af makrofag-aktiveringssyndrom hos sJIA-patienter
Diagnosis of Macrophage Activation Syndrome in sJIA patients
Diagnosticering af og prognose for symptomatisk og asymptomatisk PML differentiering mellem PML og MS o PML-behandlingsalgoritme
Diagnosis and prognosis of symptomatic and asymptomatic PML differentiation between PML and MS o PML management algorithm
Diagnostisk gruppe
Diagnostic Group
Diagnostiske laboratoriefund omfatter faldende pH i blodet, plasmalaktat-tal på over 5 mmol/l og et forhøjet anion gap og forhøjet laktat/pyruvat-forhold.
Diagnostic laboratory findings are decreased blood pH, plasma lactate levels above 5 mmol/L, an increased anion gap and lactate/pyruvate ratio.
Diagnostiske laboratoriefund omfatter nedsat pH i blodet, plasmalaktatniveau over 5 mmol/l og et forhøjet aniongap og laktat/pyruvat-forhold.
Diagnostic laboratory findings are decreased blood pH, plasma lactate levels above 5 mmol/L, and an increased anion gap and lactate/pyruvate ratio.
Diagnostiske laboratoriefund viser nedsat pH i blodet, koncentration af plasmalaktat over 5 mmol/l og øget anion-gap samt laktat/pyruvatratio.
Diagnostic laboratory findings are decreased blood pH, plasma lactate levels above 5 mmol/L, and an increased anion gap and lactate/pyruvate ratio.
Diagnostiske laboratoriefund viser nedsat pH i blodet, plasmalaktat > 5 mmol/l og øget anion-gap og laktat/pyruvatratio.
Diagnostic laboratory findings are decreased blood pH, plasma lactate levels above 5 mmol/l, and an increased anion gap and lactate/pyruvate ratio.
Diagnostiske laboratorieresultater er reduceret pH-værdi i blodet, plasma laktatværdier over 5 mmol/l og øget aniongab og laktat/pyruvat-ratio.
Diagnostic laboratory findings are decreased blood pH, plasma lactate levels above 5 mmol/l and increased anion gap and lactate/pyruvate ratio.
Diagram af hovedet, der viser retningen for administration af injektionen fra basis af øret mod dyrets modsatte øje.
Diagram of the head showing the direction for the base of the ear injections administered toward the animal’s opposite eye.
Diagram E Diagram F tilsal tilsal
Diagram E Diagram F
Diagram I
cinal cinal
Diagram L
Medicinal
Diagram over regimer med induktionstransplantation.
Induction Transplant Regimens Graph.
Diagram P til salg til salg
Diagram P
Diagrammerne A og B viser dig alle de forskellige dele af pennen og kanylen.
Diagrams A and B show you all the different parts of the pen and the injection needle.
Diagrammet nedenfor (se figur 1) viser hvordan den fyldte injektionssprøjte ser ud.
The diagram below (see figure 1) shows what the pre-filled syringe looks like.
Diagrammet nedenfor (se figur 1) viser, hvordan ”SmartJect” fyldt pen ser ud.
The diagram below (see figure 1) shows what the ”SmartJect” pre-filled pen looks like.
Diagrammet ovenfor viser virkningsprofilen over tid for insulin glargin og NPH insulin.
The graph above shows the activity profiles over time of insulin glargine and NPH insulin.
Dialyse kan imidlertid fjerne både ethanol og propylenglycol i tilfælde af overdosering med ritonavir oral opløsning
However, dialysis can remove both alcohol and propylene glycol in the case of overdose with ritonavir oral solution.
Dialyse virker måske ikke med hensyn til at fjerne tolvaptan på grund af dets høje bindingsaffinitet for human plasmaprotein (>98 %).
Dialysis may not be effective in removing tolvaptan because of its high binding affinity for human plasma protein (>98%).
Dialyseafhængige patienter (der ikke er i dialyse)
Dialysis dependent patients (off-dialysis)
Dialysepatienter, der skifter fra én ugentlig injektion til én injektion hver anden uge, skal til at begynde med have en dosis Aranesp svarende til det dobbelte af den dosis, der sidst blev givet ugentligt.
Dialysis patients converting from once weekly to once every other week dosing with Aranesp should initially receive a dose equivalent to twice the previous once weekly dose.
Dialysepatienter, der skifter fra én ugentlig injektion til én injektion hver anden uge, skal til at begynde med have en dosis Nespo svarende til det dobbelte af den tidligere ugentlige dosis.
Dialysis patients converting from once weekly to once every other week dosing with Nespo should initially receive a dose equivalent to twice the previous once weekly dose.
Diameter < 6 mm på ethvert tidspunkt
Diameter < 6 mm at any time
Diameter < 6 mm ved kortical oprensning
Diameter < 6 mm at cortical clean-up
Diare eller mavesmerter
Diarrhoea or stomach ache
Diare Opkastning Mavesmerter Kvalme Flatulens
Diarrhoea Vomiting Abdominal pain Nausea Flatulence
diare, opkastning, kvalme, mavesmerter
diarrhoea, vomiting, nausea, abdominal pain
diare, opkastning, mavesmerter/- ubehag
diarrhoea , vomiting, abdominal pain/discomfort
diarre
diarrhea
Diarre
diarrhoea
Diarre (G3/4: 2,9%);
Diarrhoea (G3/4: 2.9%);
Diarre (G3/4: 4%);
Diarrhoea (G3/4: 4%);
Diarre (vandig, løs eller blød afføring), kvalme
Diarrhoea (watery, loose or soft stools), nausea
diarre appetitløshed
diarrhoea loss of appetite
Diarre eller colitis, der opstår efter behandlingsstart med ipilimumab, skal undersøges med det samme for at udelukke infektiøse eller alternative ætiologier.
Diarrhoea or colitis occurring after initiation of ipilimumab must be promptly evaluated to exclude infectious or other alternate etiologies.
diarre, forstoppelse, kvalme, opkastning, abdominalsmerter
diarrhoea, constipation, nausea, vomiting, abdominal pain
Diarre, kvalme
Diarrhoea, feeling sick
diarre, kvalme
diarrhoea, nausea
Diarre, Kvalme
Sciatica,
diarre, opkastning eller kvalme
diarrhoea, vomiting or feeling sick (nausea)
diarre, opkastning, abdominalsmerter, gastroøsofageal reflukssygdom, obstipation, mundtørhed, flatulens
diarrhoea, vomiting, abdominal pain, gastrooesophageal reflux disease, constipation, dry mouth, flatulence
Diarre, opkastning, føle sig syg.
Diarrhoea, vomiting, feeling sick
diarre, opkastning, mavesmerter, forstoppelse, halsbrand, unormalt meget luft i maven eller tarmen
diarrhoea, vomiting, abdominal pain, constipation, heartburn, excessive gas in the stomach or bowel
diarre, stomatitis, opkastning, abdominalsmerter, obstipation, mundtørhed
diarrhoea, stomatitis, vomiting, abdominal pain, constipation, dry mouth
diarre, stomatitis, opkastning, mundsår, abdominalsmerter, glossitis, obstipation, kvalme og opkastning
diarrhoea, stomatitis, vomiting, mouth ulceration, abdominal pain, glossitis, constipation, nausea and vomiting
diarrec, opkastning, kvalme
diarrhoeac, vomiting, nausea
Diarré
56.0
Diarré
Arthralgia Myalgia
Diarré
Diarrhoe a
diarré
diarrhoea,
Diarré
Diarrhoea;
Diarré
Dyspepsia
Diarré
Nausea
Diarré
Rash
Diarré (18,7 %) (G3/4: 0,8 %)
Diarrhoea (18.7%) (G3/4: 0.8%)
Diarré (3,6 %)
Diarrhoea (3.6%)
Diarré (54%)
Diarrhoea (54%)
Diarré (G3/4: 1,2 %); Stomatitis/Pharyngitis (G3/4: 0,9 %);
Diarrhoea (G3/4: 14%);
Diarré (G3/4: 1,2%); Stomatitis/Pharyngitis (G3/4: 0,9%);
Diarrhoea (G3/4: 1.2%); Stomatitis/Pharyngitis (G3/4: 0.9%);
Diarré (G3/4: 1,7%)
Diarrhoea (G3/4: 1.7%)